While systemic VEGF blockade was initially reported to cause TMA, diverse glomerular lesions have been documented, including minimal change disease (MCD), membranous nephropathy and FSGS [10–14, 23]. Here, VEGFA is linked to focal segmental glomerulosclerosis.